Intensive family therapy - inpatient
Behavioral2-4 weeks (5days) family inpatient assessment and treatment
NCT Number: NCT00184327
Children receiving IFT (intensive family therapy) were assessed for symptom profile and global functioning before admission, 3 months after discharge and 1 year after discharge. Children were assessed by parents, children, their teachers and themselves. Parents were assessed by themselves at the same points in time through psychological self-report questionnaires.
The study is intended to explore covariates to change in children as well as in parents during (pre-treatment) the treatment and follow-up periods.
Looking for future studies?
Notify Me6 year and older
All sexes
Observational
Haukeland University Hospital, Helse Bergen, Bergen, Norway
IFT is an intensive combinatory family treatment which is child-oriented, and traditionally used in an inpatient family treatment unit in child and adolescent psychiatry.
Measures include ones on bonding (PBI), personality traits (NEO-PI), anxiety and depressive symptoms (HADS), attributional tendencies (PAT) and social desirable responding (BIDR). A subgroup was also assessed before a waiting period (pre-treatment).
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
2-4 weeks (5days) family inpatient assessment and treatment
Norwegian University of Science and Technology
Other
Change Across Intensive Inpatient Family Treatment in Child and Adolescent Psychiatry. A Multi-site Study of Parents and Children in Inpatient Family Treatment
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07043803
Bipolar Disorder, Bipolar and Related Disorders
Altoona, Pennsylvania, United States
View Trial DetailsNCT04585360
Anxiety Disorders, Behavior
Le Kremlin-Bicêtre, Val de Marne, France
View Trial DetailsNCT07294443
Anxiety, Anxiety Disorders
Istanbul, Üsküdar - Selimiye, Turkey (Türkiye)
View Trial DetailsNCT07164014
Energy Metabolism, Glucose Metabolism Disorders
Riyadh, Saudi Arabia
View Trial Details